Iris was one of seven companies formed by Weill Cornell Medicine investigators that participated in the Business Plan Challenge. The groups competed in Griffis Faculty Club in front of a panel of seven expert judges comprised of investors who specialize in early-stage companies, for investment capital for their NewCos to help commercialize their technologies.
Now an M.D.-Ph.D. student, Du Cheng was initially rejected from college and later from all but one medical school. But he has since distinguished himself by balancing the rigors of studying medicine with running his own startup, iDu Optics, which has generated more than $500,000 in revenue.
Fostering a Culture of Innovation, Weill Cornell Medicine is Making it Faster and Easier for Researchers to Move their Discoveries From Bench to Bedside
Computational Biology Student Neel Madhukar Designs a Powerful Tool for Optimizing Drug Development.
Infertility affects about 12 percent of American couples. Celmatix, a New York City-based personalized medicine company focused on reproductive health, is trying to change that.
As an undergraduate student, Du Cheng invented a laboratory camera adapter that would allow scientists to capture images with an iPhone and then view them through a microscope.
Researchers at Weill Cornell Medicine have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic—and it’s based on the Oakland A’s winning strategy, immortalized in the blockbuster book and movie Moneyball.